1. Home
  2. Browse
  3. HRA000823
HRA000823
   HRA000823.xlsx
Title:
PRAD single-cell sequencing
Release date:
2022-08-08
Description:
To systematically explore genomic and transcriptomic intra-tumoral heterogeneity cooperate to shape the evolutionary course of prostate cancer ecosystem in primary tumor of un-treated PCa patients. A total of 14 surgically resected tissue samples were collected from patients with prostate cancer, which pathological type were prostatic acinar adenocarcinoma. No endocrine therapy was conducted on all patients before surgery. Cell capture and cDNA synthesis were carried out in 10X Genomics platform, and then transcriptome sequencing was performed in NovaSeq 6000 platform after meeting the all quality control.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA004981
Study type:
Disease Study
Disease name:
prostate cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000500
DAC name:
PRAD single-cell sequencing
Contact person:
ci Weimin
Email:
ciwm@big.ac.cn
Description:
To systematically explore genomic and transcriptomic intra-tumoral heterogeneity cooperate to shape the evolutionary course of prostate cancer ecosystem in primary tumor of un-treated PCa patients. A total of 14 surgically resected tissue samples were collected from patients with prostate cancer, which pathological type were prostatic acinar adenocarcinoma. No endocrine therapy was conducted on all patients before surgery. Cell capture and cDNA synthesis were carried out in 10X Genomics platform, and then transcriptome sequencing was performed in NovaSeq 6000 platform after meeting the all quality control.
Individuals & samples
Files
Request Data
Submitter:   ci Weimin / ciwm@foxmail.com
Organization:   The Third Medical Center of Chinese PLA General Hospital
Submission date:   2021-05-10
Requests:   15